Department of Pediatrics, College of Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Department of Family and Community Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Rev Diabet Stud. 2023 Mar 31;19(1):28-33. doi: 10.1900/RDS.2023.19.28.
We aimed to study the characterizing clinical and biochemical profiles of Diabetic Ketoacidosis (DKA) in children with newly diagnosed Type 1 Diabetes Mellitus (Type 1DM) compared to children with established diagnosis of Type 1DM presenting with DKA admitted to the pediatric intensive care unit of a large university hospital in the eastern region of Saudi Arabia. We retrospectively reviewed the medical records of 211 patients who were admitted to the pediatric intensive care unit with diabetic ketoacidosis between 2010 and 2019. The diagnosis of diabetic ketoacidosis was based on symptoms of polydipsia, polyurea, weight loss, vomiting, dehydration, abdominal pain, breathing problems, lethargy or coma, biochemical hyperglycemia (blood glucose level of >200 mg/dL), venous pH of <7.3, serum bicarbonate level of ≤15 mEq/L, and ketonemia (blood β -hydroxybutyrate concentration of ≥3 mM) or moderate or severe ketonuria (diagnosed as newly acquired type 1 diabetes). The rate of newly diagnosed Type 1 DM with DKA was 41.7%, out of them who got severe and moderate diabetic ketoacidosis were 61.6% and 38.4%, respectively. We observed significantly increased heart and respiratory rates in patients newly diagnosed with diabetic ketoacidosis and in those with severe diabetic ketoacidosis (p<0.001) compared to known cases with Type 1DM presenting with DKA. We also identified significantly increased biochemical indices including HbA1c, random blood sugar, serum osmolality, blood urea nitrogen, creatinine, chloride, lactate, and anion gap in relation to severe diabetic ketoacidosis and newly diagnosed type 1 diabetes (p ≤ 0.05). We found that the clinical and biochemical profiles of patients with newly diagnosed Type 1 DM children were significantly affected compared to children who were known Type 1DM presenting with DKA.
我们旨在研究新诊断的 1 型糖尿病(Type 1DM)儿童与已确诊的 1 型糖尿病伴糖尿病酮症酸中毒(DKA)入院儿科重症监护病房的儿童的 DKA 的临床和生化特征。我们回顾性分析了 2010 年至 2019 年期间因糖尿病酮症酸中毒入住儿科重症监护病房的 211 例患者的病历。糖尿病酮症酸中毒的诊断依据是多饮、多尿、体重减轻、呕吐、脱水、腹痛、呼吸问题、嗜睡或昏迷、生化高血糖(血糖水平>200mg/dL)、静脉 pH 值<7.3、血清碳酸氢盐水平≤15mEq/L 和酮血症(血β-羟丁酸浓度≥3mM)或中度或重度酮尿症(诊断为新获得的 1 型糖尿病)。新诊断的 1 型糖尿病伴 DKA 的发生率为 41.7%,其中重度和中度糖尿病酮症酸中毒的发生率分别为 61.6%和 38.4%。与已知患有 1 型糖尿病伴 DKA 的患者相比,我们观察到新诊断为糖尿病酮症酸中毒和重度糖尿病酮症酸中毒的患者的心率和呼吸率显著增加(p<0.001)。与重度糖尿病酮症酸中毒和新诊断的 1 型糖尿病患者相关,我们还发现了显著增加的生化指标,包括 HbA1c、随机血糖、血清渗透压、血尿素氮、肌酐、氯、乳酸和阴离子间隙(p ≤ 0.05)。我们发现,与已知患有 1 型糖尿病伴 DKA 的儿童相比,新诊断的 1 型糖尿病儿童的临床和生化特征受到显著影响。